Últimas noticias sobre Jasper Therapeutics (NASDAQ:JSPR) Bolsa

Jasper Therapeutics

Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy.

Jasper Therapeutics, Inc. - Class A Common Stock

Jasper Therapeutics Inc

Macro Economic Events

News

Econ #s

Economics

Natural Gas Storage Build Of 42B Vs 34B Est.; 69B Prior

The S&amp;P 500 Index has traded higher and posted new all-time highs since the 2024 presidential election was<a href="https://www.benzinga.com/news/24/11/41768178/donald-trump-defeats-kamala-harris-to-win-2024-election"> won by Donald Trump.</a>
Benzinga readers expect the momentum to continue, with the index nearing impressive election year milestones.
What Happened: The 2024 presidential election win by Donald Trump has created market optimism <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/41784504/trumps-win-sends-indices-to-record-highs-financials-small-caps-surge-bitcoin-tops-75-000-w">across the stock market </a>and cryptocurrency sector.
While analysts and experts look for individual stocks and sectors that could benefit under four years with Trump beginning in January 2025, market indexes have soared to record levels.
The SPDR S&amp;P 500 ETF Trust (ARCA :SPY), which tracks the S&amp;P 500 Index, opened for trading at $570.74 on Election Day and closed at $576.70 the same day, ahead of Americans and people around the world knowing the election outcome.
By early morning on Nov. 6, media outlets had declared Trump the winner of the election, and the SPY opened at $589.20, up 2.2% from the previous day.
A recent poll of Benzinga readers shows that market optimism is expected since the Trump victory was declared.
"Will Trump's victory keep the stock market on a winning streak through 2024?" Benzinga asked.
The results were:
<ul>
<li>Yes: 76%</li>
<li>No: 24%</li>
</ul>
The majority of Benzinga readers expect the stock market momentum to continue after Trump's victory, likely meaning that the S&amp;P 500 will continue to gain through the end of the year.
Did You Know?
<ul>
<li>Congress Is Making Huge Investments. <a href="https://www.benzinga.com/gov-trades/?utm_source=BZprocontent111424">Get Tips On What They Bought And Sold Ahead Of The 2024 Election With Our Easy-to-Use Tool</a></li>
</ul>
Why It's Important: <a href="https://www.benzinga.com/etfs/broad-u-s-equity-etfs/23/12/36416440/why-buy-stocks-in-a-presidential-election-year-history-has-a-crazy-stat-for-you">Benzinga previously reported</a> that presidential election years are often good for investors with 14 of the last 16, not including 2024, seeing the S&amp;P 500 Index trade higher. The only two presidential election years of the last 16 to not have a positive return were the global financial crisis (2008) and the dot-com bubble (2000).
The SPDR S&amp;P 500 ETF Trust is currently up 26.4% year-to-date in 2024. While that amount could go up or down, the return is currently among the highest in recent presidential election years.
If the 26.4% gain holds or comes in higher, 2024 would mark the best-performing presidential election year for the S&amp;P 500 since 1980 (+32.4%), beating the current record holder, 1996, which saw the index up 23.1%.
The 2024 return of the S&amp;P 500 could also come as one of the best in recent years. Here are the recent returns of the S&amp;P 500 ETF Trust:
<ul>
<li>2023: +26.2%</li>
<li>2022: -18.2%</li>
<li>2021: +28.8%</li>
<li>2020: +18.4%</li>
<li>2019: +31.2%</li>
<li>2018: -4.6%</li>
<li>2017: +21.7%</li>
<li>2016: +12.0%</li>
</ul>
With the ETF up 26.4% year-to-date, the SPY is currently ahead of the 2023 return, but down from the returns posted in 2021 and 2019.
If the stock market continues to trade higher and hits record highs, there's a chance that the SPY passes those figures and could be the best performing year for the ETF in over 10 years, with 2013 being up 32.3%.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/general/politics/24/10/41584466/these-10-stocks-were-the-best-s-p-500-performers-in-2017-when-trump-was-president-will-history-r">These 10 Stocks Were The Best S&amp;P 500 Performers In 2017 When Trump Was President: Will History Repeat Itself?</a></li>
</ul>
The study was conducted by Benzinga from Nov. 6 through Nov. 7, 2024, and included the responses of a diverse population of adults 18 or older. Opting into the survey was completely voluntary, with no incentives offered to potential respondents. The study reflects results from 146 adults.
Photo: Shutterstock

Politics

Trading Ideas

Will Trump's Election Win Push S&P 500 Even Higher In Final Weeks Of 2024? Over 75% Say...

Ford Motor's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/F#NYSE">F</a>) short percent of float has risen 6.5% since its last report. The company recently reported that it has 106.07 million shares sold short, which is 2.95% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.82 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Ford Motor Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1731598224_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Ford Motor has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Ford Motor's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Ford Motor's peer group average for short interest as a percentage of float is 7.88%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

Looking Into Ford Motor's Recent Short Interest

argenx's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ARGX#NYSE">ARGX</a>) short percent of float has fallen 4.38% since its last report. The company recently reported that it has 1.70 million shares sold short, which is 2.84% of all regular shares that are available for trading. Based on its trading volume, it would take traders 7.12 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>argenx Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1731598218_0_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for argenx has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing argenx's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, argenx's peer group average for short interest as a percentage of float is 5.09%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

ARGX

(ARGX) - Analyzing argenx's Short Interest

Air Products &amp; Chemicals's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/APD#NYSE">APD</a>) short percent of float has fallen 19.19% since its last report. The company recently reported that it has 3.54 million shares sold short, which is 1.6% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.61 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Air Products &amp; Chemicals Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1731598213_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Air Products &amp; Chemicals has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Air Products &amp; Chemicals's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Air Products &amp; Chemicals's peer group average for short interest as a percentage of float is 3.12%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Peering Into Air Products & Chemicals's Recent Short Interest

ASP Isotopes Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASPI#NASDAQ">ASPI</a>) shares are trading higher. The company on Thursday announced a deal to collaborate on an advanced <a href="https://www.benzinga.com/pressreleases/24/11/g41970030/asp-isotopes-inc-enters-into-memorandum-of-understanding-with-the-south-african-nuclear-energy-cor">nuclear fuel production facility</a>.
What Happened: ASP Isotopes entered into a Memorandum of Understanding (MOU) with The South African Nuclear Energy Corporation (Necsa) to collaborate on the research, development and commercial production of advanced nuclear fuels.
The MOU contemplates the formation of a new entity in South Africa with a board consisting of at least two representatives from ASP Isotopes and Necsa. The company said discussions between the parties in recent years have centered on advancing new nuclear fuel for small modular reactors at the start, and eventually working toward a nuclear fuel facility for the production of High Assay Low-Enriched Uranium (HALEU).
&#8220;Nuclear fuel has one of the most severely compromised supply chains&nbsp;of any material in the World. The World is in urgent need of additional suppliers.&nbsp;This partnership with Necsa will enable us to accelerate the construction of an advanced nuclear fuel facility,&#8221; said Paul Mann, chairman and CEO of ASP Isotopes.
Check This Out: <a href="https://www.benzinga.com/top-stories/24/11/41915547/trumps-fossil-fuel-push-may-satisfy-ais-soaring-energy-demand-but-what-about-nuclear">Trump&#8217;s Fossil Fuel Push May Satisfy AI&#8217;s Soaring Energy Demand — But What About Nuclear?</a>
ASP Isotopes shares are up more than 100% over the past month as several nuclear names have benefitted from an increased focus from hyperscalers aiming to keep up with rising energy demand related to AI data centers. 
ASP Isotopes shares surged at the end of October after the company signed a deal with Bill Gates-backed <a href="https://www.benzinga.com/news/24/10/41624818/asp-isotopes-stock-is-soaring-wednesday-whats-going-on">TerraPower</a> related to&nbsp;the construction of a uranium enrichment facility capable of producing HALEU.
ASP on Thursday said it has received interest from potential customers who collectively require over $37 billion of HALEU between now and 2037.
ASPI Price Action: <a href="http://benzinga.com/quote/aspi" target="_blank" rel="noreferrer noopener">ASP Isotopes shares</a> were up 5.32% at $7.88 at the time of publication Thursday, according to <a href="http://pro.benzinga.com/" target="_blank" rel="noreferrer noopener">Benzinga Pro</a>.
Photo: Shutterstock.

Contracts

Movers

ASPI

ASP Isotopes Stock Is Moving Higher Thursday: What's Going On?

RBC Capital analyst Sabahat Khan maintains Finning International (TSX:<a class="ticker" href="https://www.benzinga.com/stock/FTT#TSX">FTT</a>) with a Outperform and lowers the price target from C$50 to C$46.

Price Target

Analyst Ratings

TSX:FTT

RBC Capital Maintains Outperform on Finning International, Lowers Price Target to C$46

Truist Securities analyst Neal Dingmann maintains Riley Exploration Permian (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/REPX#AMEX">REPX</a>) with a Buy and raises the price target from $40 to $45.

REPX

Truist Securities Maintains Buy on Riley Exploration Permian, Raises Price Target to $45

Scotiabank analyst Nicholas Yulico maintains UDR (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UDR#NYSE">UDR</a>) with a Sector Perform and lowers the price target from $49 to $48.

Scotiabank Maintains Sector Perform on UDR, Lowers Price Target to $48

RBC Capital analyst Jimmy Shan maintains H&amp;R REIT (TSX:<a class="ticker" href="https://www.benzinga.com/stock/HR#TSX">HR</a>) with a Sector Perform and raises the price target from C$11 to C$11.5.

TSX:HR

TSX:HR/UN

RBC Capital Maintains Sector Perform on H&R REIT, Raises Price Target to C$11.5

Scotiabank analyst Nicholas Yulico maintains Mid-America Apartment (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MAA#NYSE">MAA</a>) with a Sector Perform and lowers the price target from $174 to $173.

Scotiabank Maintains Sector Perform on Mid-America Apartment, Lowers Price Target to $173

Scotiabank analyst Nicholas Yulico maintains Equity Residential (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EQR#NYSE">EQR</a>) with a Sector Perform and lowers the price target from $81 to $78.

Scotiabank Maintains Sector Perform on Equity Residential, Lowers Price Target to $78

RBC Capital analyst Irene Nattel reiterates Loblaw Cos (TSX:<a class="ticker" href="https://www.benzinga.com/stock/L#TSX">L</a>) with a Outperform and maintains C$205 price target.

Reiteration

TSX:L

RBC Capital Reiterates Outperform on Loblaw Cos, Maintains C$205 Price Target

<a href="https://news.bitcoin.com/bitcoin-com-now-live-on-rumble-a-new-era-for-crypto-content" title="https://news.bitcoin.com/bitcoin-com-now-live-on-rumble-a-new-era-for-crypto-content">https://news.bitcoin.com/bitcoin-com-now-live-on-rumble-a-new-era-for-crypto-content</a>

Shares Of Rumble See Volume; Bitcoin.com Now Live on Rumble Platform

Truist Securities analyst Jailendra Singh maintains Doximity (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DOCS#NYSE">DOCS</a>) with a Hold and raises the price target from $35 to $49.

DOCS

Truist Securities Maintains Hold on Doximity, Raises Price Target to $49

Scotiabank analyst Nicholas Yulico maintains Camden Prop Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CPT#NYSE">CPT</a>) with a Sector Perform and lowers the price target from $132 to $130.

Scotiabank Maintains Sector Perform on Camden Prop Trust, Lowers Price Target to $130

Truist Securities analyst Ki Bin Kim reiterates CyberArk Software (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CYBR#NASDAQ">CYBR</a>) with a Buy and raises the price target from $300 to $350.

CYBR

Truist Securities Reiterates Buy on CyberArk Software, Raises Price Target to $350

RBC Capital analyst Irene Nattel reiterates Maple Leaf Foods (TSX:<a class="ticker" href="https://www.benzinga.com/stock/MFI#TSX">MFI</a>) with a Outperform and maintains C$29 price target.

TSX:MFI

RBC Capital Reiterates Outperform on Maple Leaf Foods, Maintains C$29 Price Target

Scotiabank analyst Nicholas Yulico maintains AvalonBay Communities (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AVB#NYSE">AVB</a>) with a Sector Perform and lowers the price target from $244 to $241.

Scotiabank Maintains Sector Perform on AvalonBay Communities, Lowers Price Target to $241

Truist Securities analyst Neal Dingmann maintains Coterra Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CTRA#NYSE">CTRA</a>) with a Buy and raises the price target from $31 to $33.

CTRA

Truist Securities Maintains Buy on Coterra Energy, Raises Price Target to $33

Virtual Meeting to be held with CEO Martell and CFO Cross on October 22 hosted by Jefferies. Published first on TheFly – the ultimate source for re...

Jasper Therapeutics management to meet virtually with Jefferies

Analyst Tim Chiang of Capital One Financial assigned a Buy rating on Jasper Therapeutics (JSPR – Research Report), with a price target of $55.00. T...

Buy Rating on Jasper Therapeutics Driven by Promising Clinical Developments and Strategic Advancements

Jasper Therapeutics (JSPR – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Silvan Tuerkcan ...

Promising Developments and Competitive Edge: Jasper Therapeutics' Buy Rating

Jasper Therapeutics GAAP EPS of -$1.24 misses by $0.17

TD Cowen analyst Yaron Werber has maintained their bullish stance on JSPR stock, giving a Buy rating on October 29. Yaron Werber has given his Buy ...

Promising Outlook for Jasper Therapeutics: Buy Rating Reinforced by Advancements in Briquilimab

Analyst Emily Bodnar of H.C. Wainwright maintained a Buy rating on Jasper Therapeutics (JSPR – Research Report), reducing the price target to $60.0...

Positive Expectations and Clinical Success Drive Buy Rating for Jasper Therapeutics

Strong Buy Rating for Jasper Therapeutics Driven by Promising Briquilimab Developments and Solid Cash Position

Jasper Therapeutics, Inc. ( ($JSPR) ) has released its Q3 earnings. Here is a breakdown of the information Jasper Therapeutics, Inc. presented to i...

Jasper Therapeutics Advances in Antibody Therapy Development

In a report released yesterday, Gregory Renza from RBC Capital maintained a Buy rating on Jasper Therapeutics (JSPR – Research Report), with a pric...

Jasper Therapeutics (JSPR) Gets a Buy from RBC Capital

In a report released today, Jay Olson from Oppenheimer maintained a Buy rating on Jasper Therapeutics (JSPR – Research Report), with a price target...

Comments

Jasper Therapeutics

Noticias

Últimas noticias sobre Jasper Therapeutics (NASDAQ:JSPR) Bolsa

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL